Combination Therapy Archives | Page 4 of 4

CureMatch Partnering with Patient Power to Educate and Empower Cancer Patients and Oncologists

Cancer Patients Combination Therapy Genomics

The goal is to accelerate the adoption of genomics and combination therapy in oncology to increase standard of care for cancer patients SAN DIEGO, CA – March 30, 2017 – CureMatch, the developer of a decision support system for personalized combination therapy for cancer, and Patient Power, an online news source for cancer patients, today […]

CureMatch featured on healthcare startup blog Minds of Malady

Cancer Combination Therapy

Morten Björklund discusses the challenges of cancer treatment and CureMatch’s new approach to personalized combination therapy, on his healthcare startup blog Minds of Malady.

Study shows Combination Therapy to be more effective than Single-Drug Therapy

Cancer Combination Therapy Personalized Medicine

A study of 136 patients with advanced cancers performed by UCSD oncologist and CureMatch co-founder Dr. Razelle Kurzrock and colleagues suggested that combination therapy may be more efficacious than single-drug therapy.

Genomic Profiling May Be Beneficial For Patients With Multiple Genomic Aberrations

Combination Therapy Genomic Profiling Matching Score

A study was performed of more than 300 patients with diverse refractory cancers, including ovarian cancer, breast cancer, sarcoma, and renal cancer who had undergone next-generation sequencing of their tumor. “Matching Scores” were calculated for each patient based on the number of drug matches and genomic aberrations. It was found that high Matching Scores were […]

Matching Scores and Combination Therapy May Lead to Improved Outcomes

Cancer Combination Therapy Matching Score

An observational study of 180 patients with solid advanced cancers found that matching patients with drugs targeting their genomic anomalies was associated with better outcomes. Further, when a “Matching Score” that integrated the number of matches and number of alterations was used, the Matching Score was predictive of longer survival. The study also suggested that […]

Launch of CureMatch Certified Precision Oncology Recognition Award
CureMatch, a leader in precision oncology, is proud to announce the establishment of the CureMatch...
CureMatch Announces Collaboration with Mark Cuban Cost Plus Drug Company to Promote Affordable Cancer Treatment
CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to...
CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments
CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision...
The Complex Cancer Puzzle | Video 1
CureMatch and Mprobe Partner to Help Cancer Patients Determine Optimal Treatments
CureMatch will leverage mProbe’s targeted proteomics platform to assess individual proteins within patients’ tumor tissues....
CureMatch Granted CPT® Code by American Medical Association for its Algorithmic Cancer Therapy Ranking Service
Oncologists will be able to submit claims to payers using a Category III CPT code,...
CureMatch CEO Navid Alipour named a Top 50 Honoree Leader of Influence in Life Science by San Diego Business Journal
Congratulations to CureMatch CEO Navid Alipour for being named a Top Leader of Influence in...

Combination Therapy

CureMatch Partnering with Patient Power to Educate and Empower Cancer Patients and Oncologists

CureMatch featured on healthcare startup blog Minds of Malady

Study shows Combination Therapy to be more effective than Single-Drug Therapy

Genomic Profiling May Be Beneficial For Patients With Multiple Genomic Aberrations

Matching Scores and Combination Therapy May Lead to Improved Outcomes

Please fill out the information below and a CureMatch representative will reach out to you.

Physician Request

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data